Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 3 Multicenter Comparative Study to Confirm Safety and Effectiveness of the F(ab)2 Antivenom Anavip.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00636116
Recruitment Status : Completed
First Posted : March 14, 2008
Last Update Posted : January 10, 2012
Sponsor:
Collaborators:
Universidad Nacional Autonoma de Mexico
University of Arizona
Information provided by (Responsible Party):
Instituto Bioclon S.A. de C.V.

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : November 2011
Actual Study Completion Date : January 2012
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 March 18, 2016
April 18, 2016